Doctor lauded for championing clinical research

HUNTERSVILLE – The Association of Community Cancer Centers awarded John Powderly II with the 2014 David King Community Clinical Scientist Award on April 2 at its national meeting.

The award recognizes his dedication to cancer research and education, as well as promoting the goals of cancer prevention, early detection and quality cancer treatment.

Powderly serves as president of the Carolina BioOncology Institute in Huntersville, as well as an adjunct clinical assistant professor of medicine at Duke University and UNC-Chapel Hill. The oncologist is also the only certified physician investigator in the Charlotte region.

“As a research clinician, Dr. Powderly exemplifies the spirit of Dr. King for whom this national award was named,” ACCC President Virginia Vaitones said. “Like Dr. King, Dr. Powderly has spent his career championing the value of the community clinical oncology program and raising awareness of the role of clinical research in the community cancer setting.”

The award is named after Dr. David King, who died after a brief battle with cancer. King dedicated his career to caring for people with cancer, as well as advocating for access to quality care and the value of clinical research.

Powderly founded the Carolina BioOncology Institute in 2005. The cancer therapy and research facility is dedicated to advancing the field of cancer research by making available the latest developments in therapeutic options. 

The community-based clinic focuses on early phase immunotherapy trials, which represent the cutting edge in immunotherapy and personalized cancer options. 

In addition to treating almost 3,000 patients, CBI has opened more than 50 early phase clinical trials and serves as a regional referral hub for Phase I access.

“To be recognized for our hard work in fighting cancer and providing access to immunotherapy trials to patients in the Charlotte area is a wonderful validation of the clinic’s mission,” Powderly said.


Want to learn more? Additional information about Carolina BioOncology Institute and the cancer trials open for enrollment can be found at